(Q45074381)

9 December 2017

title

Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment (English)

1 reference

primary biliary cholangitis

9 December 2017

1 reference

0 references

author name string

Meri Koulentaki

1

1 reference

9 December 2017

Joanna Moscandrea

2

1 reference

9 December 2017

Philipos Dimoulios

3

1 reference

9 December 2017

Costas Chatzicostas

4

1 reference

9 December 2017

Elias A Kouroumalis

5

1 reference

9 December 2017

publication date

1 August 2004

1 reference

Digestive Diseases and Sciences

9 December 2017

published in

1 reference

9 December 2017

volume

49

1 reference

9 December 2017

issue

7-8

1 reference

9 December 2017

page(s)

1190-1195

1 reference

Survival in ursodeoxycholic acid-treated patients with biliary cirrhosis

9 December 2017

cites work

1 reference

12 December 2020

Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?

1 reference

12 December 2020

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

12 December 2020

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

1 reference

12 December 2020

Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.

1 reference

12 December 2020

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

1 reference

12 December 2020

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

12 December 2020

A note on the calculation of expected survival, illustrated by the survival of liver transplant patients

1 reference

12 December 2020

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display

1 reference

12 December 2020

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

12 December 2020

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

1 reference

12 December 2020

Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients

1 reference

12 December 2020

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

12 December 2020

Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma

1 reference

12 December 2020

Serum bilirubin: a prognostic factor in primary biliary cirrhosis

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis.

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression

1 reference

12 December 2020

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

12 December 2020

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

The ursodeoxycholic acid story in primary biliary cirrhosis

1 reference

12 December 2020

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

12 December 2020

A note on the calculation of expected survival, illustrated by survival of liver transplant patients by B.L. Thomsen, N. Keiding and D.G. Altman, Statistics in Medicine, 10, 733-738 (1991)

1 reference

12 December 2020

Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates

1 reference

12 December 2020

10.1023/B:DDAS.0000037811.48575.DA

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1029769460

0 references

1 reference